Wutah pendapatan triwulanan: PainReform (PRFX)

Simbol lan logo merek PainReform Limited (PRFX)

PainReform Ltd. (PRFX) develops innovative long-term pain management solutions that reduce the need for opioids. However, success depends on FDA approval and the clinical superiority of the PLFE drug. The current commercialization stage requires external financing due to high marketing costs. On GURU.Markets, the quarterly revenue change history demonstrates financial dynamics, where the value 0.00 shows the current magnitude of this metric.

PRFX Wutah dodolan kuartal marang kuartal PainReform Limited (04.07.2022 - 20.11.2026)

Rincian analitis lan laporan data perusahaan PainReform (PRFX)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analisis perusahaan:PRFX - PainReform Ltd
Produk sing diprodhuksi painreform.com

This indicator measures the percentage change in revenue between the current and previous quarters, allowing for an assessment of commercial expansion rates driven by market liquidity. By analyzing the change in quarterly sales volume, an investor can see the lack of stable cash flows for PainReform Ltd. (PRFX), which confirms the drug development stage and the dependence of future revenues on the successful completion of clinical trials.

Pesaing utama

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Verona Pharma (VRNA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Amneal Pharmaceuticals Inc AMRX|Wutah pendapatan triwulanan PRGO|Owah-owahan dodolan kuartal marang kuartal ALVO|Wutah pendapatan triwulanan LQDA (Liquidia Technologies)|Wutah pendapatan triwulanan Galapagos GLPG|ANI Pharmaceuticals Inc - Wutah pendapatan triwulanan|MNKD (MannKind Corp.) - Wutah dodolan kuartal marang kuartal|AMPH: Wutah pendapatan triwulanan|PCRX (Pacira BioSciences) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ARS Pharmaceuticals Inc|Wutah dodolan triwulanan Theravance Biopharma, Inc. (TBPH)|Wutah dodolan triwulanan AQST (Aquestive Pharma)|SCPH - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan TECX (Tectonic Therapeutic, Inc.)|TNXP - Wutah dodolan triwulanan|China SXT Pharmaceuticals, Inc. - Wutah pendapatan triwulanan|EPRX - Wutah pendapatan triwulanan|BHST: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ENTX (Entera Bio)|Wutah pendapatan kuartal marang kuartal MindWalk (HYFT)|Wutah pendapatan triwulanan ABVC BioPharma, Inc. (ABVC)|Wutah pendapatan kuartal marang kuartal Cumberland Corp CPIX|QNTM - Wutah dodolan triwulanan|FGEN - Wutah pendapatan kuartal marang kuartal|TELO - Wutah pendapatan triwulanan|Rani Therapeutics Inc (RANI) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal SNYR|Wutah pendapatan kuartal marang kuartal Rallybio Corp|Wutah pendapatan kuartal marang kuartal LEXX|Wutah pendapatan triwulanan PULM|PTHL: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan APM (Aptorum Group Ltd)|LYRA - Wutah dodolan triwulanan|Impact BioMedical Inc - Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal TNFA|YCBD (cbdmd.com) - Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Altamira Therapeutics (CYTO)|Wutah pendapatan kuartal marang kuartal Lipella Pharmaceuticals, Inc.|OPTN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Pieris (PIRS)|Wutah pendapatan triwulanan Procaps Group Corp (PROC)|Wutah pendapatan triwulanan PTPI (petrospharma.com)|Tambahing pendapatan triwulanan QLI|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)